| Trial ID: | L1504 |
| Source ID: | NCT02487706
|
| Associated Drug: |
Dolutegravir
|
| Title: |
Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
HIV
|
| Interventions: |
DRUG: Dolutegravir
|
| Outcome Measures: |
Primary: hemodialysis extraction ratio of dolutegravir, Day 5|hemodialysis clearance of dolutegravir, Day 5 | Secondary: percentage of patients presenting adverse events related to dolutegravir, From Baseline to day 5
|
| Sponsor/Collaborators: |
Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
5
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2015-06
|
| Completion Date: |
2015-07
|
| Results First Posted: |
|
| Last Update Posted: |
2015-10-01
|
| Locations: |
Germans Trias i Pujol Hospital, Badalona, Barcelona, 08916, Spain
|
| URL: |
https://clinicaltrials.gov/show/NCT02487706
|
